Triple
T16852080
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Veklury |
E409698
|
entity |
| Predicate | targets |
P860
|
FINISHED |
| Object |
SARS-CoV-2 RNA-dependent RNA polymerase
SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
|
E1236235
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SARS-CoV-2 RNA-dependent RNA polymerase | Statement: [Veklury, targets, SARS-CoV-2 RNA-dependent RNA polymerase]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 RNA-dependent RNA polymerase Context triple: [Veklury, targets, SARS-CoV-2 RNA-dependent RNA polymerase]
-
A.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
B.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
C.
SARS-CoV
SARS-CoV is the coronavirus responsible for the 2002–2004 SARS outbreak, causing severe respiratory illness in humans.
-
D.
SARS-CoV-2 lineage B.1.617
SARS-CoV-2 lineage B.1.617 is a major coronavirus lineage first identified in India that includes several notable variants, such as the highly transmissible Delta variant, associated with significant global COVID-19 waves.
-
E.
Betacoronavirus
Betacoronavirus is a genus of enveloped, positive-sense RNA viruses that includes several notable human and animal pathogens, such as the viruses causing SARS, MERS, and COVID-19.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: SARS-CoV-2 RNA-dependent RNA polymerase Triple: [Veklury, targets, SARS-CoV-2 RNA-dependent RNA polymerase]
Generated description
SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 RNA-dependent RNA polymerase Target entity description: SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
-
A.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
B.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
C.
SARS-CoV
SARS-CoV is the coronavirus responsible for the 2002–2004 SARS outbreak, causing severe respiratory illness in humans.
-
D.
SARS-CoV-2 lineage B.1.617
SARS-CoV-2 lineage B.1.617 is a major coronavirus lineage first identified in India that includes several notable variants, such as the highly transmissible Delta variant, associated with significant global COVID-19 waves.
-
E.
Betacoronavirus
Betacoronavirus is a genus of enveloped, positive-sense RNA viruses that includes several notable human and animal pathogens, such as the viruses causing SARS, MERS, and COVID-19.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d88395e6c88190b22730f335107c14 |
completed | April 10, 2026, 4:59 a.m. |
| NER | Named-entity recognition | batch_69e3b37abadc81909d02d329403497d6 |
completed | April 18, 2026, 4:38 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a00bb216fac81909d401c6b9911d1e0 |
completed | May 10, 2026, 5:06 p.m. |
| NEDg | Description generation | batch_6a00bb9b2b1881908f9f5c3dd1a2d500 |
completed | May 10, 2026, 5:08 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a00bc3a4b888190bd190b9330e2777d |
completed | May 10, 2026, 5:11 p.m. |
Created at: April 10, 2026, 5:24 a.m.